ICLR News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

IC

Mkt Cap

$13.14B

Volume

554.98K

Next Earnings

October 27th

Loading chart

IC

ICLRIcon Plc

ICLR

Pay with—

Available Balance0.00

IC

Mkt Cap

$13.13B

Volume

554.98K

Next Earnings

October 27th

Chart Financials Earnings News About Insider Filings

Rare Disease Contract Research Organization (CRO) Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share OutlookThe global rare disease CRO market is projected to grow from $2.07 billion in 2025 to $3.16 billion by 2030, with an 8.9% CAGR. Growth is driven by expanding gene and cell therapy pipelines, increasing orphan drug approvals, precision medicine adoption, and decentralized clinical trials. Key trends include AI integration, patient registries, and real-world evidence utilization.GlobeNewswire Inc. · Sep 21, 2026

CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?CVS Health reported strong Q2 2026 results with adjusted EPS of $2.58 (up 42.5% YoY) and revenues of $106.10 billion (up 7.3%), beating consensus estimates. The company raised full-year 2026 guidance for earnings and revenues. However, estimates have trended downward over the past month with a -6.08% consensus shift, and the stock received a Zacks Rank #3 (Hold) rating with expectations for in-line returns.Zacks Investment Research · Sep 4, 2026

[Latest] Global eClinical Solutions Market Size/Share Worth USD 42.55 Billion by 2035 at a 13.98% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)The global eClinical Solutions market is projected to grow from USD 11.50 billion in 2025 to USD 42.55 billion by 2035, at a CAGR of 13.98%. Growth is driven by increased demand for efficient clinical trials, rising chronic disease prevalence, adoption of AI and cloud computing technologies, and decentralized trial models. Key players include Oracle, Veeva Systems, IQVIA, Medidata Solutions, and IBM Watson Health.GlobeNewswire Inc. · Aug 5, 2026

Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate GrowthThe global clinical trials market is projected to grow from $127.16 billion in 2025 to $176.32 billion by 2030, with a CAGR of 6.8%. Growth is driven by AI-enabled trial design, decentralized and virtual trials, precision medicine, and real-world evidence studies. North America leads the market while Asia-Pacific is the fastest-growing region. Strategic consolidation continues with major acquisitions strengthening end-to-end capabilities.GlobeNewswire Inc. · Jul 15, 2026

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in ICON plc (ICLR) to Contact Law FirmMoore Law PLLC is investigating ICON plc (NASDAQ: ICLC) following the company's announcement of an internal audit committee investigation into accounting practices and controls initiated in October 2025. ICON's stock price dropped significantly on February 12, 2026, when the company disclosed the investigation and delayed its earnings release to April 30, 2026.GlobeNewswire Inc. · Jul 9, 2026

Why Icon Stock Crushed it on WednesdayIcon Public (ICLR), a clinical research organization, surged nearly 11% on Wednesday after delivering first-quarter 2026 results that beat analyst expectations. While revenue grew modestly by 0.9% to $2 billion and net income fell 27%, the company's gross bookings jumped 22% year-over-year to $3.3 billion, signaling strong demand for its services in the biotech and pharmaceutical sectors.The Motley Fool · Jun 24, 2026

Global Decentralized Clinical Trials Market Size/Share Worth USD 38.3 Billion by 2035 at a 14.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)The global decentralized clinical trials market is projected to grow from USD 9.9 billion in 2025 to USD 38.3 billion by 2035, at a CAGR of 14.5%. Growth is driven by digital health technologies, remote patient engagement, and ecosystem expansion involving CROs and platform vendors. Oncology represents the largest therapeutic segment at 45% market share, while pharmaceutical and biotech sponsors lead end-user adoption at 55% market share. North America currently dominates, while Asia-Pacific shows the fastest growth.GlobeNewswire Inc. · Jun 22, 2026

Clinical Trial Data Visualization Research Report 2026: $1.82 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FThe clinical trial data visualization market is projected to grow from $0.89 billion in 2025 to $1.82 billion by 2030 at a CAGR of 15.4%, driven by increasing adoption of AI-powered solutions, cloud-based platforms, and decentralized trials. Major players include ICON plc, Oracle Corporation, and IQVIA Inc., with Asia-Pacific emerging as the fastest-growing region.GlobeNewswire Inc. · Apr 24, 2026

eCOA, eSource and Clinical Trials Research Report 2026: $81.46 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FThe eCOA, eSource, and clinical trials market is projected to grow from $51.15 billion in 2025 to $81.46 billion by 2030 at a 9.8% CAGR, driven by AI adoption, decentralized trial models, and digital transformation. Key growth factors include regulatory acceptance of electronic records, cloud-based systems, and real-time data capture. Despite tariff challenges, regional software development is strengthening market resilience.GlobeNewswire Inc. · Apr 24, 2026

ICLR SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsICON Public Limited Company's Audit Committee is investigating accounting practices and internal controls related to revenue recognition from fiscal years 2023-2025. The company disclosed material weaknesses in internal controls, delayed financial results, and withdrew 2025 guidance. ICON shares fell approximately 40% on the announcement, declining from $133.14 to $80.08 per share on February 12, 2026.GlobeNewswire Inc. · Feb 20, 2026

to start trading

IC

ICLRIcon Plc

ICLR

Pay with—

Available Balance0.00

Your PositionYou don't own any ICLR yet.

Related Tickers

Earnings